Cargando…
Susceptibility of β-Lactam Antibiotics and Genetic Mutation of Drug-Resistant Mycobacterium tuberculosis Isolates in Korea
BACKGROUND: Mycobacterium tuberculosis (Mtb) is resistant to the β-lactam antibiotics due to a non-classical transpeptidase in the cell wall with β-lactamase activity. A recent study showed that meropenem combined with a β-lactamase inhibitor clavulanate, was effective in MDR and XDR tuberculosis (T...
Autores principales: | Park, Sanghee, Jung, Jihee, Kim, Jiyeon, Han, Sang Bong, Ryoo, Sungweon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Tuberculosis and Respiratory Diseases
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263340/ https://www.ncbi.nlm.nih.gov/pubmed/35586904 http://dx.doi.org/10.4046/trd.2021.0175 |
Ejemplares similares
-
Investigation of Clofazimine Resistance and Genetic Mutations in Drug-Resistant Mycobacterium tuberculosis Isolates
por: Park, Sanghee, et al.
Publicado: (2022) -
Molecular Analysis of Anti-Tuberculosis Drug Resistance of Mycobacterium tuberculosis Isolated in the Republic of Korea
por: Jeon, Se-Mi, et al.
Publicado: (2023) -
A comparison of phenotypic and WGS drug susceptibility testing in Mycobacterium tuberculosis isolates from the Republic of Korea
por: Lee, Seung Heon, et al.
Publicado: (2023) -
Evaluation of MGIT 960 System for the Second-Line Drugs Susceptibility Testing of Mycobacterium tuberculosis
por: Kim, Hyejin, et al.
Publicado: (2013) -
BCG vaccine in Korea
por: Joung, Sun Myung, et al.
Publicado: (2013)